Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2026-03-07 @ 9:31 PM
Study NCT ID:
NCT02349503
Status:
WITHDRAWN
Last Update Posted:
2015-06-11
First Post:
2015-01-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
Sponsor:
Neurocrine Biosciences
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Congenital Adrenal Hyperplasia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Adrenocortical function | View |
| None | Adrenal hyperplasia, Congenital | View |
| None | 21-hydroxylase deficiency | View |
| None | Adrenogenital Syndrome | View |
| None | Adolescents | View |
| None | Female | View |
| None | Hyperplasia | View |
| None | Adrenal Gland Diseases | View |
| None | Congenital Abnormalities | View |
| None | Adrenocortical Hyperfunction | View |
| None | Disorders of Sex Development | View |
| None | Endocrine System Diseases | View |
| None | Genetic Diseases, Inborn | View |
| None | Gonadal Disorders | View |
| None | Metabolic Diseases | View |
| None | Metabolism, Inborn Errors | View |
| None | Pathologic Processes | View |
| None | Steroid Metabolism, Inborn Errors | View |
| None | Urogenital Abnormalities | View |
| None | Corticotropin Releasing Factor | View |